Company news
Nuvo Pharmaceuticals Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Nuvo Research Announces 2013 Third Quarter Results
October 30, 2013
Nuvo Research® to Receive US$2.0 Million
October 10, 2013
Nuvo Research® Announces Scientific Presentations at Annual Painweek 2013 Meeting
September 5, 2013
Nuvo Research® announces that FDA has accepted Pennsaid® 2% new drug application for review
August 22, 2013
Nuvo Research® announces lawsuit against Mallinckrodt
August 21, 2013
Nuvo announces Mallinckrodt submits PK study report in response to PENNSAID® 2% FDA complete response letter
August 15, 2013
Nuvo Research announces 2013 second quarter results
July 31, 2013
Nuvo Research® announces update to Pennsaid® 2% Complete Response Letter
July 23, 2013
Nuvo Research® and Paladin Labs announce completion of the loan arrangement
July 10, 2013
Galen to acquire U.S. rights for Synera® from Nuvo Research®
July 10, 2013
Nuvo Research Announces Director Election Results of its Annual General Meeting
June 18, 2013
Nuvo Research® and Paladin Labs announce amendment to May 2012 loan arrangement
June 17, 2013
Nuvo Research announces scientific presentations at the Annual Meeting of the American College of Sports Medicine
May 30, 2013
Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of Immunologists
May 16, 2013
Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10
May 14, 2013
Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%
May 9, 2013
Nuvo Research to Complete Share Consolidation
May 7, 2013
Nuvo Research announces 2013 First Quarter Results
May 1, 2013
Nuvo Research announces European launch of Pliaglis® by Galderma
April 23, 2013
Nuvo Research announces scientific presentation at the Annual Meeting of the American Medical Society for Sports Medicine
April 19, 2013
Nuvo Research announces 2012 Fourth Quarter & Year-End Results
March 27, 2013
Nuvo Research provides additional information regarding Pennsaid 2%
March 18, 2013
Nuvo Research announces U.S. launch of Pliaglis® by Galderma
March 11, 2013
Nuvo Research announces FDA response to PENNSAID® 2% NDA
March 5, 2013
Nuvo Research announces settlement agreement with Apotex in PENNSAID® generic litigation
January 29, 2013
Nuvo Research announces 2012 third quarter results
October 31, 2012
Notice of Nuvo Research 2012 third quarter results conference call
October 29, 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis®
October 22, 2012
Nuvo Research obtains additional U.S. Patent for PENNSAID® 2%
September 5, 2012
Nuvo Research announces 2012 second quarter results
August 1, 2012
Nuvo Research receives?4.4 million additional funding to develop WF10
July 26, 2012
Nuvo Research announces new listing of Synera® Patent in FDA Orange Book
July 25, 2012
Nuvo Research provides a PENNSAID® franchise update
July 23, 2012
Nuvo Research to Receive US$6.0 Million of Milestone Payments from Pliaglis® E.U. Approvals
July 19, 2012
Nuvo Research provides PENNSAID® commercial update
June 14, 2012
Nuvo Research and Paladin Labs Sign Canadian License Agreement for Synera and a Loan Agreement
May 28, 2012
Pliaglis receives positive opinion from the BfArM in the E.U.
May 7, 2012
Nuvo Research Announces 2012 First Quarter Results
May 2, 2012
FDA issues complete response letter for the Pliaglis sNDA submission
April 18, 2012
Nuvo Research Provides Pennsaid® Update
April 12, 2012
Nuvo Research to Present at the Roth Capital 24th Annual Growth Stock Conference
March 6, 2012
Nuvo Research announces 2011 fourth quarter & year-end results
February 29, 2012
Nuvo Research provides an update on its Pennsaid® franchise
February 23, 2012
Pliaglis® Regulatory Update
February 21, 2012
Nuvo Research announces launch of Synera® in the U.S.
February 2, 2012
Nuvo Research announces management change
January 9, 2012
Nuvo Research to increase ownership in Nuvo Research AG to 100 percent
December 5, 2011
Nuvo Research Provides PENNSAID Commercial Update
November 14, 2011
Nuvo Research Announces 2011 Third Quarter Results
November 2, 2011
Nuvo Research provides update on the PENNSAID Viscous Solution development program
September 14, 2011